Novobiocin (0.613 g, 0.001 mol) and dibromozinc (1.126 g, 0.005 mol) were carefully dissolved in 20 mL of hot ethanoic acid and maintained 24 hours at 50°C. Cyclonovobiocin crystallized as translucent needles. A suitable crystal was taken for diffraction studies.
Discussion
Novobiocin is a coumarin antibiotic first discovered in Streptomyces spheroides [1] . The biological activity is due to the inhibition of bacterial DNA gyrase [1] . Recent works demonstrated that novobiocin can bind to the C-terminal nucleotide-binding region of hsp90 leading to decrease in hsp90 client proteins in various cancer cell lines [2] . However, novobiocin exhibits a weak inhibitory activity against hsp90. As a part of our work concerning structure-activity relationships for novobiocin and hsp90, new noviose-free novobiocin analogs have been prepared. Cyclonovobiocinic acid, obtained after acidic hydrolysis of novobiocin [3] , was studied by X-ray crystallography. The title compound is an amide having a 3-amino-4,7-dihydroxy-8-methylcoumarin (A) and 3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-6-carboxylic acid (B). The coumarin entity (A) has a planar conformation with a largest deviation of 0.045(2) Å for C12 from the best plane P1 (C2-C7/O9/C10/C12/C13), defined by two six-member rings P2 (C2/C7) and P3 (C5/C6/O9/C10/ C12/C13) which make a dihedral angle of 3.1(1)°. Electron localization was found at the short C12C13 bond with a length of 1.367(3) Å. The wide angle of C12C13O14 and the narrow angle of O14C13C5 give the hydroxy group a tilt to the C4 direction. In B entity, the atoms C25 and C26 are displaced out of the 
